Phesi Powers Data-Driven Clinical Trials Through Addition of New Country Selection Functionality to ClinSite

Article

Phesi, on Aug. 5 announced a new country selection functionality has been added to ClinSite, its platform to provide investigator site intelligence to clients, enabling investigator site selection and management. The new functionality has been added in response to the industry-wide problem of non-performing countries and sites being included in clinical trials. ClinSite is an AI-powered tool including data from 4.2m physicians and 600,000 investigator sites, identified from over 80,000 sources and 330,000 clinical trials in more than 200 countries. The country selection functionality is powered by real-time enrolment data from live trials and will allow users to select top-performing countries and sites globally when planning a trial.

For more information, click here.

Recent Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.